Clinical benefits of stabilisation with second line chemotherapy in patients with metastatic colorectal cancer.
Henry
B
B
ARCOS (Analyses et Recherches en Economie de la Santé), Issy les Moulineaux, France. bhenry-launois@arcos.fr
Becouarn
Y
Y
Aussage
P
P
D000970:Antineoplastic Agents / Q000191:economics* / Q000627:therapeutic use; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000191:economics* / Q000473:pathology; D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis; D005602:France; D017721:Hospital Costs; D006801:Humans; D007902:Length of Stay / Q000191:economics; D009362:Neoplasm Metastasis; D010166:Palliative Care / Q000191:economics*; D010343:Patient Admission / Q000191:economics; D011446:Prospective Studies; D011788:Quality of Life; D018434:Sickness Impact Profile
D000970:Antineoplastic Agents